Actinic Keratoses
97
8
15
59
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
23 trials with published results (24%)
Research Maturity
59 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.2%
6 terminated out of 97 trials
90.8%
+4.3% vs benchmark
34%
33 trials in Phase 3/4
39%
23 of 59 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 59 completed trials
Clinical Trials (97)
Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum
Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp
Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage
Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead
Efficacy and Safety of Cryotherapy Versus 5-Fluorouracil in the Treatment of Actinic Keratosis
Comparison of Nicotinamide Treatments for Actinic Keratosis
Actinic Keratoses Treatment With Metvix® in Combination With Light
Investigation of the Effect of Lipikar Baume AP+M
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis
PDT vs Peels for Treatment of Actinic Keratoses
Immunotherapy After Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients
OCT and Invasion in Cutaneous Skin Lesions
Patient Decision Aid for the Treatment of Actinic Keratosis
The Influence of an E-learning Program on Recognition of Actinic Keratosis
High- and Low-risk Actinic Keratosis Referrals to Secondary Care
Implementation of Actinic Keratosis Guideline Among General Practitioners.